Vast amounts of complex data are generated through tumour molecular profiling techniques. Expert review is needed to translate tumour molecular profiles into clinical benefit for patients.

Learn how members of a Molecular Tumour Board (MTB) come together to discuss and interpret tumour molecular profiles in the clinical context, recommending therapeutic strategies for the care of patients with cancer.

Gain insights into the challenges of balancing evidence and real world expectations.

Four (4) self contained webinars, over a 4-week period from 29th October 2020 to 19th November 2020.

Each webinar will focus on one or more specific aspects of tumour molecular profiling that are the subject of MTB discussion.

Register here